CD8A and neoplasm: We also identified that CD8+ T cell‐related gene signature and deconvolution including memory CD8+ T cell [47] and CD8+TIL signature [16] had a strong ability to predict pCR to iCIT, which indicates that therapies fostering tumor infiltration of lymphocytes alone or combined with ICI may prolong survival in patients with initially lower expression of TILs [48].